FOCUSED SEGMENTED ELECTRODE

• US 20080097566A1
• Filed: 07/13/2007
• Published: 04/24/2008
• Est. Priority Date: 07/13/2006
• Status: Abandoned Application

• Current Assignee: Proteus Biomedical, Inc. (Otsuka Holdings Company Limited)
• Original Assignee: Proteus Biomedical, Inc. (Otsuka Holdings Company Limited)
• Inventors: Colliou, Olivier
• Application Number:
  US11/777,981
• Publication Number:
  US 20080097566A1
• Time in Patent Office: Days
• US Class Current: 607/122
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 2001/0585 Coronary sinus electrodes

Abstract

The present invention provides significantly improved electrode structures, including segmented electrode structures, which are able to deliver highly focused energy to tissue when implanted into a patient. Embodiments of the invention include focused segmented electrodes. Also provided are leads that include the focused segmented electrodes, implantable pulse generators that include the leads, as well as systems and kits having components thereof, and methods of making and using the subject devices.

Claims

1. An implantable elongated flexible structure comprising a proximal end and a distal end, wherein said structure further comprises a focused segmented electrode, wherein said focused segmented electrode comprises two or more electrodes conductively coupled to an individually addressable processor, wherein said electrodes are configured to deliver tissue-focused stimulation.

2. The implantable elongated flexible structure according to claim 1, wherein said focused segmented electrode comprises electrodes positioned on only one side of said lead.

3. The implantable elongated flexible structure according to claim 2, wherein said focused segmented electrode comprises a series of juxtaposed strip electrodes.

4. The implantable elongated flexible structure according to claim 1, wherein said focused segmented electrode comprises a central electrode and one or outer electrodes peripherally arranged about said central electrode.

5. The implantable elongated flexible structure according to claim 4, wherein said focused segmented electrode comprises a single outer electrode that circumscribes said central electrode.

6. The implantable elongated flexible structure according to claim 4, wherein said focused segmented electrode comprises two or more outer electrodes that collectively circumscribe said central electrode.

7. The implantable elongated flexible structure according to claim 1, wherein said structure is a vascular lead.

8. The implantable elongated flexible structure according to claim 7, wherein said vascular lead comprises 2 or more individually addressable focused segmented electrodes.

9. The implantable elongated flexible structure according to claim 8, wherein said vascular lead is a multiplex lead having 3 or less wires.

10. The elongated flexible structure according to claim 9, wherein said vascular lead includes only 2 wires.

11. The elongated flexible structure according to claim 10, wherein said vascular lead includes only 1 wire.

12. The elongated flexible structure according to claim 11, wherein said vascular lead includes an IS-1 connector at said proximal end.

13. An implantable pulse generator comprising:

(a) a housing comprising a power source and an electrical stimulus control element; and

(b) a vascular lead comprising a focused segmented electrode, wherein said focused segmented electrode comprises two or more electrodes conductively coupled to an individually addressable processor, wherein said electrodes are configured to deliver tissue-focused stimulation.

14. The implantable pulse generator according to claim 13, wherein said control element is configured to operate said implantable pulse generator as a pacemaker.

15. The implantable pulse generator according to claim 13, wherein said control element is configured to operate said implantable pulse generator in a manner sufficient to achieve cardiac resynchronization.

16. A method comprising:

(a) implanting into a patient an implantable pulse generator comprising;

(i) a housing comprising a power source and an electrical stimulus control element; and

(ii) a vascular lead comprising a focused segmented electrode, wherein said focused segmented electrode comprises two or more electrodes conductively coupled to an individually addressable processor, wherein said electrodes are configured to deliver tissue-focused stimulation; and

(b) delivering electrical stimulation to tissue of said patient from said focused segmented electrode.

17. The method according to claim 16, wherein said tissue is cardiac tissue.

18. The method according to claim 17, wherein said method is a method of cardiac pacing.

19. The method according to claim 17, wherein said method is a method of cardiac resynchronization therapy.

20. A kit comprising:

(a) a housing comprising a power source and an electrical stimulus control element; and

(b) a vascular lead comprising a focused segmented electrode, wherein said focused segmented electrode comprises two or more electrodes conductively coupled to an individually addressable processor, wherein said electrodes are configured to deliver tissue-focused stimulation.